share_log

HC Wainwright & Co. Reiterates Buy on Aridis Pharmaceuticals, Maintains $2 Price Target

HC Wainwright & Co. Reiterates Buy on Aridis Pharmaceuticals, Maintains $2 Price Target

HC Wainwright & Co.重申买入Aridis Pharmicals,维持2美元的目标股价
Benzinga ·  2023/11/06 07:05

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aridis Pharmaceuticals (OTC:ARDS) with a Buy and maintains $2 price target.

HC Wainwright & Co. 分析师弗农·贝纳迪诺重申Aridis Pharmicals(场外交易代码:ARDS)买入并维持2美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发